5414x

Co-founder and CEO announced he will step down from his role and the board by the end of 2026.

: £13.0 million (+52.9%), driven by AMR and EMEAI growth. Co-founder and CEO announced he will step down

: £72.1 million, a 22.1% increase compared to H1 2024 (£59.0 million). Gross Profit : £61.4 million, up 24% year-on-year. Co-founder and CEO announced he will step down

: Established a strategic collaboration with Cepheid (a Danaher subsidiary) to develop automated infectious disease sequencing solutions. Leadership Update Co-founder and CEO announced he will step down

The full text and detailed report of this "paper" (regulatory announcement) include the following key sections and financial highlights: